Clinical trial · no report yet · Phase 1/Phase 2
NCT06341114
A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors
- NCT06341114 ↗
- Active, not recruiting
- Bio-Thera Solutions
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| X threads | 3 |
The trial
ClinicalTrials.gov- Official title
- A Multicenter, Open-label Phase Ib-II Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors
- Phase
- Phase 1/Phase 2
- Status
- Active, not recruiting
- Conditions
- Advanced Solid Tumors
- Interventions
- BAT8008 injection; BAT1308 injection
- Arms
- A/ Standard 3+3 2.1mg/kg of BAT8008 · Experimental
- B/ Standard 3+3 2.4mg/kg of BAT8008 · Experimental
- Standard 3+3 200mg of BAT1308 · Experimental
- A/ Standard 3+3 1.8mg/kg of BAT8008 · Experimental
- B/ Standard 3+3 2.1mg/kg of BAT8008 · Experimental
- Standard 3+3 300mg of BAT1308 · Experimental
- Enrollment
- 112 (estimated)
- Primary outcomes
- Dose-limiting toxicity (DLT)
- vital signs
- Physical examination
- Adverse events
- Clinical laboratory tests
- Clinical auxiliary tests
- Objective response rate (ORR)
- Duration of Response(DOR)
- Disease Control Rate (DCR)
- Progression Free Survival(PFS)
- Overall Survival(OS)
- Sponsor
- Bio-Thera Solutions
- Start
- Apr 12, 2024
- Primary completion
- Nov 30, 2026 (estimated)
- Results posted
- No
- Registry record
- NCT06341114 · updated Oct 2, 2026